Rami Komrokji, MD, Moffitt Cancer Center
Advertisement
Articles by Rami Komrokji, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
The Role of Supportive CarePublished: November 18th 2020 | Updated:
Heterogeneity and Presentation of MDSPublished: November 18th 2020 | Updated:
Ensuring an Accurate DiagnosisPublished: November 18th 2020 | Updated:
The Role of Hypomethylating Agents and TransplantationPublished: November 18th 2020 | Updated:
The Future of MDS ManagementPublished: November 18th 2020 | Updated:
Overview of Luspatercept-aamt as MDS TreatmentPublished: November 18th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5